Shortly after in early November, Neon will present potentially a broader set of results on NEO-PV-01 at the Society of Immunotherapy of Cancer (SITC) Annual Meeting taking place from November 9-11 in Washington D.C. However, it is also pla...查看全文
忘江2018-10-22 13:34
$BioLineRx Ltd. - American Depositary Shares(BLRX)$
The results presented today at a poster discussion session at the European Society for Medical Oncology 2018 Congress, in Munich, Germany, demonstrate that BL-8040 significantly improves T-cell infiltration into the tum...查看全文
忘江2018-10-21 17:00
$Neon Therapeutics, Inc.(NTGN)$
Background
Neoantigens arise from DNA mutations in cancer cells and are important targets for T cells. Adjuvant therapy with a personal neoantigen vaccine induced T cell responses in melanoma (mel) patients and suggested synergy with a...查看全文
用户18509225712018-10-19 12:13
Neonode ® to Report Third Quarter 2018 Results on November 8, 2018:网页链接
STOCKHOLM, Oct. 18, 2018 /PRNewswire/ -- Neonode Inc., (NASDAQ: NEON), the Optical...查看全文
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000062 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000063 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000064 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000065 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000066 Size: 8 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000067 Size: 8 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000068 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000069 Size: 10 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000070 Size: 12 KB 网页链接
$Neon Therapeutics(NTGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001694187-20-000071 Size: 10 KB 网页链接